OriGen Biomedical cut the ribbon on its new Austin headquarters and manufacturing facility on Sunday, October 18, moving its operations 22 miles across the city to an 82,000-square-foot campus at 2215 Grand Avenue Parkway in North Austin. The relocation more than doubles the company's previous footprint, according to a company news release, and brings a sterile fill suite, expanded office and collaboration areas, and modern manufacturing infrastructure to the site.
The company makes freezing bags used to cool and store biological materials, along with bags designed to protect and store cells and tissues, products that support the cell and gene therapy industry's cryopreservation and cell culture needs. As reported by Community Impact Newspaper, the new facility includes 6,600 square feet of cleanroom space. The company previously operated at 7000 Burleson Road.
A Redesigned Cleanroom Built for Tenfold Growth
CEO Beth San Segundo told the outlet in April that the move would enable a dramatic production increase. In the company's own release, San Segundo called the opening an important milestone after nearly 30 years of growth in Austin. She described the facility as representing continued investment in people, technology, and manufacturing capabilities meant to serve customers and support the development of new therapies.
Clearing Regulatory Hurdles in 98 Countries
OriGen's account of the transition describes market-specific regulatory assessments across 98 global markets and discusses possible compliance filings to maintain international sales. International quality standards including ISO 13485 and the Medical Device Single Audit Program underscore how tightly regulated medical device manufacturing remains, even for a domestic relocation.
OriGen's product line includes freezing bags used for cryopreservation and cell culture.
OriGen's Austin Roots
OriGen was founded in Austin in 1997 to develop single-use specialty medical devices. San Segundo is the company's president and CEO. As of April 2026, OriGen employed nearly 200 people in the Austin area and operated as an employee-owned business.
Part of a Growing North Austin Biotech Corridor
OriGen's expansion lands amid a broader buildout of life-sciences real estate in North and Northwest Austin. In January, Karlin Real Estate lined up a $610M lab-life makeover of the former 1.1-million-square-foot 3M corporate campus nearby. Construction was scheduled to begin in March, with the project set to convert more than 100 acres near River Place Boulevard into lab-ready research space. The following month, city planners reviewed a 374-acre rezoning initiative around UT Austin's J.J. Pickle Research Campus aimed at building an integrated medical and life-sciences hub near The Domain, part of a pattern of zoning updates meant to accommodate expanded clinical and research facilities in the area.
